Selected Grants
Prospective clinical evaluation of photon-counting CT for body oncology applications through investigational patient studies
Clinical TrialPrincipal Investigator · Awarded by Siemens Medical Solutions USA, Inc. · 2022 - 2025Simulation Tools for 3D and 4D CT and Dosimetry
ResearchInvestigator · Awarded by National Institutes of Health · 2007 - 2025Photon Counting Computed Tomography for Detection of Small Liver Metastases: Comparison to Conventional and Dual-Energy Systems
ResearchCo Investigator · Awarded by Society of Abdominal Radiology · 2022 - 2024CT Research Fellowship in Dual Energy and Deep Learning Image Reconstruction
FellowshipPrincipal Investigator · Awarded by GE Healthcare · 2019 - 2020LowEr Administered Dose with highEr Relaxivity: Gadovist vs Dotarem (LEADER 75)
ResearchPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2018 - 2020Dual-Shot NCOM Power Contract Injector Study
Clinical TrialPrincipal Investigator · Awarded by Nemoto Kyorindo Co., Ltd. · 2015 - 2019Optimization of a Frequency-Based Fusion Technique for Improving the Image Quality on Low Energy Virtual Monochromatic Images from Dual Energy CT
FellowshipPrincipal Investigator · Awarded by Radiological Society of North America · 2016 - 2017Decreased Variability for Robust Imaging-based Quantification of Tumor Heterogeneity
ResearchPrincipal Investigator · Awarded by Radiological Society of North America · 2015 - 2017Toward Precise and Accurate Assessment of Dose Reduction Using Iterative Reconstruction Methods for Abdominal Imaging Applications
ResearchPrincipal Investigator · Awarded by Society of Abdominal Radiology · 2015 - 2016External Relationships
- Bracco Diagnostics, Inc.
- GE Healthcare Pharmaceutical Diagnostics
- Merck Sharpe & Dohme (Merck & Co, USA)
- Pfizer Inc.
- Regeneron Pharmaceuticals
- Siemens Medical Solutions
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.